Cargando…

Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling

Background: The aim of this study was to explore the combined efficacy ofeffective-component compatibility of Bufei Yishen formula III (ECC-BYF III) and exercise rehabilitation (ER) in inhibiting airway mucus hypersecretion in a chronic obstructive pulmonary disease (COPD) rat model. Methods: A tota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Kexin, Ma, Jindi, Lu, Ruilong, Shao, Xuejie, Zhao, Yakun, Cui, Lili, Qiu, Zhiguang, Tian, Yange, Li, Jiansheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2023
Materias:	Respiratory System
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643050/ https://www.ncbi.nlm.nih.gov/pubmed/36799253 http://dx.doi.org/10.1042/BSR20222669

Ejemplares similares

Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway
por: Ma, Jindi, et al.
Publicado: (2022)

Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling
por: Ma, Jindi, et al.
Publicado: (2019)

Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model
por: Li, Jiansheng, et al.
Publicado: (2014)

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
por: Li, Jiansheng, et al.
Publicado: (2015)

Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats
por: Tian, Yange, et al.
Publicado: (2015)

Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats
por: Tian, Yange, et al.
Publicado: (2016)

Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS
por: Yang, Liping, et al.
Publicado: (2015)

Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-κB Signaling
por: Jin, Fanli, et al.
Publicado: (2022)

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease
por: Zhao, Peng, et al.
Publicado: (2018)

System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling
por: Li, Jiansheng, et al.
Publicado: (2016)

Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway
por: Tian, Yange, et al.
Publicado: (2017)

Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
por: Wang, Weimin, et al.
Publicado: (2023)

Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD
por: Zhao, Peng, et al.
Publicado: (2016)

Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS
por: Wu, Jinyan, et al.
Publicado: (2022)

Exosomal miR-150 partially attenuated acute lung injury by mediating microvascular endothelial cells and MAPK pathway
por: Xu, Jiaxin, et al.
Publicado: (2021)

Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review
por: Tianxing, Guo, et al.
Publicado: (2019)

Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD
por: Zhao, Peng, et al.
Publicado: (2015)

Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD
por: Zhao, Peng, et al.
Publicado: (2017)

Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats
por: Lu, Xiaofan, et al.
Publicado: (2016)

Bronchial Thermoplasty for Severe Asthma with Mucus Hypersecretion
por: Nagano, Naoko, et al.
Publicado: (2019)

Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway
por: Li, Min-yan, et al.
Publicado: (2022)

Association of the CFTR gene with asthma and airway mucus hypersecretion
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2021)

Discovery of a drug to treat airway mucus hypersecretion
por: Dickey, Burton F., et al.
Publicado: (2022)

Network Pharmacology and Experimental Validation to Reveal Effects and Mechanisms of Icariin Combined with Nobiletin against Chronic Obstructive Pulmonary Diseases
por: Lu, Ruilong, et al.
Publicado: (2022)

Epithelial barrier function properties of the 16HBE14o- human bronchial epithelial cell culture model
por: Callaghan, Patrick J., et al.
Publicado: (2020)

miR-143-3p impacts on pulmonary inflammatory factors and cell apoptosis in mice with mycoplasmal pneumonia by regulating TLR4/MyD88/NF-κB pathway
por: Wang, Yongjun, et al.
Publicado: (2020)

Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis
por: He, Min, et al.
Publicado: (2020)

Blood routine test in mild and common 2019 coronavirus (COVID-19) patients
por: Djakpo, Dodji Kossi, et al.
Publicado: (2020)

The potency of lncRNA MALAT1/miR-155/CTLA4 axis in altering Th1/Th2 balance of asthma
por: Liang, Zhijun, et al.
Publicado: (2020)

LncRNA MIR155HG contributes to smoke-related chronic obstructive pulmonary disease by targeting miR-128-5p/BRD4 axis
por: Song, Jie, et al.
Publicado: (2020)

Association between serum adiponectin concentrations and chronic obstructive pulmonary disease: a meta-analysis
por: Lin, Yi-Hua, et al.
Publicado: (2020)

Salidroside mitigates skeletal muscle atrophy in rats with cigarette smoke-induced COPD by up-regulating myogenin and down-regulating myostatin expression
por: Zhang, Dan, et al.
Publicado: (2019)

Adrenomedullin regulated by miRNA-574-3p protects premature infants with bronchopulmonary dysplasia
por: Gong, Xiaohui, et al.
Publicado: (2020)

Effects of neuromuscular electrical stimulation on exercise capacity and quality of life in COPD patients: a systematic review and meta-analysis
por: Wu, Xu, et al.
Publicado: (2020)

Hydrogen gas represses the progression of lung cancer via down-regulating CD47
por: Meng, Jinghong, et al.
Publicado: (2020)

Genetic polymorphisms as non-modifiable susceptibility factors to laryngeal cancer
por: Escalante, Paula, et al.
Publicado: (2020)

BACH1, the master regulator of oxidative stress, has a dual effect on CFTR expression
por: NandyMazumdar, Monali, et al.
Publicado: (2021)

Ebselen abolishes vascular dysfunction in influenza A virus-induced exacerbations of cigarette smoke-induced lung inflammation in mice
por: Brassington, Kurt, et al.
Publicado: (2022)

RAGE-mediated functional DNA methylated modification contributes to cigarette smoke-induced airway inflammation in mice
por: Li, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ignva06s3tiuepmlmfq8bbm2e